136 related articles for article (PubMed ID: 17368594)
1. Analysis in vivo of antitumor activity, cytotoxicity and Interaction between plasmid DNA and the cis-dichloro-tetra-amine-ruthenium(III) chloride.
Menezes CS; de Paula Costa LC; de Melo Rodrigues Avila V; Ferreira MJ; Vieira CU; Pavanin LA; Homsi-Brandeburgo MI; Hamaguchi A; de Paula Silveira-Lacerda E
Chem Biol Interact; 2007 Apr; 167(2):116-24. PubMed ID: 17368594
[TBL] [Abstract][Full Text] [Related]
2. The ruthenium complex cis-(dichloro)tetraammineruthenium(III) chloride presents selective cytotoxicity against murine B cell lymphoma (A-20), murine ascitic sarcoma 180 (S-180), human breast adenocarcinoma (SK-BR-3), and human T cell leukemia (Jurkat) tumor cell lines.
Silveira-Lacerda Ede P; Vilanova-Costa CA; Hamaguchi A; Pavanin LA; Goulart LR; Homsi-Brandenburgo MI; Dos Santos WB; Soares AM; Nomizo A
Biol Trace Elem Res; 2010 Jun; 135(1-3):98-111. PubMed ID: 19727575
[TBL] [Abstract][Full Text] [Related]
3. The ruthenium complex cis-(Dichloro)Tetraammineruthenium(III) chloride presents immune stimulatory activity on human peripheral blood mononuclear cells.
Silveira-Lacerda Ede P; Vilanova-Costa CA; Pereira Fde C; Hamaguchi A; Pavanin LA; Goulart LR; Homsi-Brandenburgo MI; Soares AM; dos Santos WB; Nomizo A
Biol Trace Elem Res; 2010 Mar; 133(3):270-83. PubMed ID: 19590831
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds.
Guichard SM; Else R; Reid E; Zeitlin B; Aird R; Muir M; Dodds M; Fiebig H; Sadler PJ; Jodrell DI
Biochem Pharmacol; 2006 Feb; 71(4):408-15. PubMed ID: 16360645
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic and genotoxic effects of cis-(dichloro)tetraammineruthenium(III) chloride on human peripheral blood lymphocytes.
Ribeiro Ade S; da Silva CC; Pereira Fde C; Lima AP; Vilanova-Costa CA; Aguiar SS; Pavanin LA; da Cruz AD; Silveira-Lacerda Ede P
Biol Trace Elem Res; 2009 Sep; 130(3):249-61. PubMed ID: 19214395
[TBL] [Abstract][Full Text] [Related]
7. Lack of In vitro cytotoxicity, associated to increased G(2)-M cell fraction and inhibition of matrigel invasion, may predict In vivo-selective antimetastasis activity of ruthenium complexes.
Zorzet S; Bergamo A; Cocchietto M; Sorc A; Gava B; Alessio E; Iengo E; Sava G
J Pharmacol Exp Ther; 2000 Dec; 295(3):927-33. PubMed ID: 11082425
[TBL] [Abstract][Full Text] [Related]
8. Rapid tumor regression caused by antitumor polysaccharide and induction of tumor-regressing factor in the serum of tumor-bearing mice.
Kunimoto T; Baba H; Nitta K
J Biol Response Mod; 1986 Apr; 5(2):160-7. PubMed ID: 3734842
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, interaction with double-helical DNA and biological activity of the water soluble complex cis-dichloro-1,2-propylenediamine-N,N,N',N'-tetraacetato ruthenium (III) (RAP).
Vilaplana RA; Delmani F; Manteca C; Torreblanca J; Moreno J; García-Herdugo G; González-Vílchez F
J Inorg Biochem; 2006 Nov; 100(11):1834-41. PubMed ID: 16959320
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic and genotoxic effects of cis-tetraammine(oxalato)ruthenium(III) dithionate on the root meristem cells of Allium cepa.
Pereira Fde C; Vilanova-Costa CA; de Lima AP; Ribeiro Ade S; da Silva HD; Pavanin LA; Silveira-Lacerda Ede P
Biol Trace Elem Res; 2009 Jun; 128(3):258-68. PubMed ID: 19020813
[TBL] [Abstract][Full Text] [Related]
11. A new nitrosyl ruthenium complex: synthesis, chemical characterization, in vitro and in vivo antitumor activities and probable mechanism of action.
Heinrich TA; Von Poelhsitz G; Reis RI; Castellano EE; Neves A; Lanznaster M; Machado SP; Batista AA; Costa-Neto CM
Eur J Med Chem; 2011 Sep; 46(9):3616-22. PubMed ID: 21665332
[TBL] [Abstract][Full Text] [Related]
12. DNA as a possible target for antitumor ruthenium(III) complexes.
Gallori E; Vettori C; Alessio E; Vilchez FG; Vilaplana R; Orioli P; Casini A; Messori L
Arch Biochem Biophys; 2000 Apr; 376(1):156-62. PubMed ID: 10729201
[TBL] [Abstract][Full Text] [Related]
13. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
14. Antitumor properties of a sulfated polysaccharide from the red seaweed Champia feldmannii (Diaz-Pifferer).
Lins KO; Bezerra DP; Alves AP; Alencar NM; Lima MW; Torres VM; Farias WR; Pessoa C; de Moraes MO; Costa-Lotufo LV
J Appl Toxicol; 2009 Jan; 29(1):20-6. PubMed ID: 18651721
[TBL] [Abstract][Full Text] [Related]
15. Effects of some ruthenium chelates on MCa mammary carcinoma and on TLX5 lymphoma in mice.
Bregant F; Pacor S; Ghosh S; Chattopadhyay SK; Sava G
Anticancer Res; 1993; 13(4):1011-7. PubMed ID: 8352519
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of dimethyl tin 4-cyclohexyl thiosemicarbazone as a novel antitumor agent.
Sen A; Chaudhuri TK
Exp Oncol; 2009 Mar; 31(1):22-6. PubMed ID: 19300412
[TBL] [Abstract][Full Text] [Related]
17. [The inhibitory effects of Realgar bioleaching solution on S180 ascites-tumor and its toxicity].
Xie QJ; Zhang X; Wang X; Bai L; Li HY
Zhong Yao Cai; 2009 Jun; 32(6):933-6. PubMed ID: 19764334
[TBL] [Abstract][Full Text] [Related]
18. Ruthenium complexes endowed with potent anti-Trypanosoma cruzi activity: Synthesis, biological characterization and structure-activity relationships.
Donnici CL; Araújo MH; Oliveira HS; Moreira DR; Pereira VR; de Assis Souza M; de Castro MC; Leite AC
Bioorg Med Chem; 2009 Jul; 17(14):5038-43. PubMed ID: 19539479
[TBL] [Abstract][Full Text] [Related]
19. The ruthenium complex cis-(dichloro)tetrammineruthenium(III) chloride induces apoptosis and damages DNA in murine sarcoma 180 cells.
de Lima AP; Pereira Fde C; Vilanova-Costa CA; Ribeiro Ade S; Pavanin LA; Dos Santos WB; Silveira-Lacerda Ede P
J Biosci; 2010 Sep; 35(3):371-8. PubMed ID: 20826946
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of two derivatives from 2-acylamine-1, 4-naphthoquinone in mice bearing S180 tumor.
Bezerra DP; Alves AP; de Alencar NM; Mesquita Rde O; Lima MW; Pessoa C; de Moraes MO; Lopes JN; Lopes NP; Costa-Lotufo LV
J Exp Ther Oncol; 2008; 7(2):113-21. PubMed ID: 18771085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
